Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Obinutuzumab, Ibrutinib, and Venetoclax in CLL
NCT02427451Phase 2Active, not recruiting
- Start
- Aug 2015
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of venetoclax in chronic lymphocytic leukemia (CLL). Started Aug 2015; status: active, not recruiting.
02
Drugs
venetoclax
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT02427451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02427451.